AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Lin, FYC Ho, VA Khiem, HB Trach, DD Bay, PV Thanh, TC Kossaczka, Z Bryla, DA Shiloach, J Robbins, JB Schneerson, R Szu, SC Lanh, MN Hunt, S Trinh, L Kaufman, JB
Citation: Fyc. Lin et al., The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children, N ENG J MED, 344(17), 2001, pp. 1263-1269

Authors: Passwell, JH Harlev, E Ashkenazi, S Chu, CY Miron, D Ramon, R Farzan, N Shiloach, J Bryla, DA Majadly, F Roberson, R Robbins, JB Schneerson, R
Citation: Jh. Passwell et al., Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel, INFEC IMMUN, 69(3), 2001, pp. 1351-1357

Authors: Taranger, J Trollfors, B Lagergard, T Sundh, V Bryla, DA Schneerson, R Robbins, JB
Citation: J. Taranger et al., Correlation between pertussis toxin IgG antibodies in postvaccination seraand subsequent protection against pertussis, J INFEC DIS, 181(3), 2000, pp. 1010-1013

Authors: Pavliakova, D Moncrief, JS Lyerly, DM Schiffman, G Bryla, DA Robbins, JB Schneerson, R
Citation: D. Pavliakova et al., Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: Studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in mice, INFEC IMMUN, 68(4), 2000, pp. 2161-2166

Authors: Konadu, EY Lin, FYC Ho, VA Thuy, NTT Bay, PV Thanh, TC Khiem, HB Trach, DD Karpas, AB Li, J Bryla, DA Robbins, JB Szu, SC
Citation: Ey. Konadu et al., Phase 1 and phase 2 studies of Salmonella enterica serovar Paratyphi A O-specific polysaccharide-tetanus toroid conjugates in adults, teenagers, and 2-to 4-year-old children in Vietnam, INFEC IMMUN, 68(3), 2000, pp. 1529-1534

Authors: Trollfors, B Taranger, J Lagergard, T Sundh, V Bryla, DA Schneerson, R Robbins, JB
Citation: B. Trollfors et al., Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis, CLIN INF D, 28(3), 1999, pp. 552-559

Authors: Ashkenazi, S Passwell, JH Harlev, E Miron, D Dagan, R Farzan, N Ramon, R Majadly, F Bryla, DA Karpas, AB Robbins, JB Schneerson, R
Citation: S. Ashkenazi et al., Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children, J INFEC DIS, 179(6), 1999, pp. 1565-1568

Authors: Kossaczka, Z Lin, FYC Ho, VA Thuy, NTT Van Bay, P Thanh, TC Khiem, HB Trach, DD Karpas, A Hunt, S Bryla, DA Schneerson, R Robbins, JB Szu, SC
Citation: Z. Kossaczka et al., Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2-to 4-year-old children in Vietnam, INFEC IMMUN, 67(11), 1999, pp. 5806-5810

Authors: Pavliakova, D Chu, CY Bystricky, S Tolson, NW Shiloach, J Kaufman, JB Bryla, DA Robbins, JB Schneerson, R
Citation: D. Pavliakova et al., Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in mice, INFEC IMMUN, 67(10), 1999, pp. 5526-5529
Risultati: 1-9 |